IL-1β induction and IL-6 suppression are associated with aggravated neuronal damage in a lipopolysaccharide-pretreated kainic acid-induced rat pup seizure model

Neuroimmunomodulation. 2012;19(5):319-25. doi: 10.1159/000339579. Epub 2012 Jul 12.

Abstract

Objectives: Reportedly, hippocampal neuronal degeneration by kainic acid (KA)-induced seizures in rats <14 days old was enhanced by lipopolysaccharide (LPS). This study was to test the hypothesis that cytokines such as interleukin (IL)-1β, IL-6 and tumor necrosis factor-α are associated with aggravated neuronal damage.

Materials and methods: Sixty male Sprague-Dawley, 14-day-old rats were used. Experiments were conducted in saline, LPS + saline, saline + KA and LPS + KA groups. Intraperitoneal LPS injections (0.04 mg/kg) were administered 3 h prior to KA injection (3 mg/kg).

Results: The LPS + KA group showed a tendency toward shorter latency to seizure onset (p = 0.086) and significantly longer seizure duration (p < 0.05) compared with the KA group. Induction of the proconvulsant cytokine IL-1β in rat pup brains was significantly greater in the LPS + KA group compared to the KA group (38.8 ± 5.5 vs. 9.2 ± 1.0 pg/µg; p < 0.05); however, IL-6 levels were higher in the KA group than in the LPS + KA group (108.7 ± 6.8 vs. 60.9 ± 4.7 pg/µg; p < 0.05). The difference in tumor necrosis factor-α between the LPS + KA group and the KA group was insignificant (12.1 ± 0.6 vs. 10.9 ± 2.3 pg/µg; p = 0.64).

Conclusions: Our results showed an increase in the proconvulsant cytokine IL-1β and a decrease in a potentially neuroprotective cytokine, IL-6, in rat pups treated with LPS + KA. These results warrant further investigation into the possible role of IL-1β induction and IL-6 suppression in LPS-promoted neuronal damage.

MeSH terms

  • Animals
  • Animals, Newborn
  • Body Temperature / drug effects
  • Brain Injuries / etiology*
  • Brain Injuries / prevention & control*
  • Cytokines / metabolism*
  • Disease Models, Animal
  • Excitatory Amino Acid Agonists / toxicity
  • Female
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Hippocampus / pathology
  • Interleukin-1beta / metabolism
  • Interleukin-6 / metabolism
  • Kainic Acid / toxicity
  • Lipopolysaccharides / administration & dosage*
  • Male
  • Neuroprotective Agents / administration & dosage*
  • Rats
  • Rats, Sprague-Dawley
  • Reaction Time / drug effects
  • Seizures / chemically induced
  • Seizures / complications*
  • Seizures / drug therapy
  • Statistics, Nonparametric
  • Status Epilepticus / chemically induced
  • Status Epilepticus / complications
  • Time Factors
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Cytokines
  • Excitatory Amino Acid Agonists
  • Interleukin-1beta
  • Interleukin-6
  • Lipopolysaccharides
  • Neuroprotective Agents
  • Tumor Necrosis Factor-alpha
  • Kainic Acid